Jaguar Health (JAGX) Cash & Current Investments (2014 - 2026)

Jaguar Health (JAGX) has reported Cash & Current Investments for 13 consecutive years, with $10.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Current Investments rose 76.87% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $10.1 million (up 76.87% YoY), while the FY2025 annual figure was $7.8 million, down 2.12% from the prior year.
• Cash & Current Investments rose to $10.1 million in Q1 2026 per JAGX's latest filing, from $7.8 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $17.5 million in Q1 2022 and bottomed at $2.2 million in Q2 2025.
• Historically, Cash & Current Investments has averaged $9.0 million across 5 years, with a median of $8.6 million in 2023.
• Annual changes were most pronounced in 2024 — Cash & Current Investments jumped 311.31% — and 2025, when it sank 86.25%.
• Jaguar Health's Cash & Current Investments stood at $5.5 million in 2022, then advanced by 18.28% to $6.5 million in 2023, then rose by 23.7% to $8.0 million in 2024, then slipped by 2.12% to $7.8 million in 2025, then advanced by 28.5% to $10.1 million in 2026.
• Business Quant data shows JAGX's Cash & Current Investments at $10.1 million in Q1 2026, $7.8 million in Q4 2025, and $3.5 million in Q3 2025.